Cited by 54HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Substance use stigma and antiretroviral therapy adherence among a drug-using population living with HIV

Open access
Stringer, Kristi Lynn, Marotta, Phillip, Baker, Elizabeth, Turan, Bulent, Kempf, Mirjam-Colette, Drentea, Patricia, Stepanikova, Irena, Turan, Janet M.·2019·AIDS Patient Care and STDs

Abstract

Among people living with HIV (PLWH), HIV-related stigma predicts nonadherence to antiretroviral therapy (ART); however, the role of stigma associated with drug use is largely unknown. We examined the association between substance use (SU) stigma and optimal ART adherence in a sample of 172 self-reported HIV-infected drug users. Participants completed surveys on SU, stigma, and ART adherence. The three substance classes with the greatest number of participants exhibiting moderate/high-risk scores were for cocaine/crack cocaine (66.28%), cannabis (64.53%), and hazardous alcohol consumption (65.70%). Multivariable logistic regression was conducted to investigate associations between levels of SU stigma and optimal ART adherence, adjusting for sociodemographic characteristics, severity of illicit drug use (alcohol, smoking and substance involvement screening test) and alcohol use severity (Alcohol Use Disorders Identification Test-C), HIV-related stigma, and social support. The odds of optimal adherence among participants experiencing moderate [Adjusted Odds Ratio (AOR) = 0.36, p = 0.039] and very high (AOR = 0.25, p = 0.010) levels of anticipated SU stigma were significantly lower than participants experiencing low levels of anticipated SU stigma. No other stigma subscales were significant predictors of ART adherence. Interventions aiming to improve ART adherence among drug-using PLWH need to address anticipated SU stigma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/apc.2018.0311

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Experiences of substance use stigma and negative perceptions about addiction treatment are associated with adverse healthcare outcomes such as impaired utilization of and retention in addiction treatment, less access to harm reduction services, and reduced ART adherence.

    “Experiences of substance use stigma and negative perceptions about addiction treatment are associated with adverse healthcare outcomes such as impaired utilization of and retention in addiction treatment, less access to harm reduction services, and reduced ART adherence.5, 6, 7, 8”

    From An acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs—a randomized clinical trial (2023) · cites this paper as [5]

    The introduction (indexed under Abstract; page unavailable) reports that substance-use stigma negatively affects access to and use of substance-use treatment and harm reduction services, and predicts attrition from treatment. The Discussion (page unavailable) reports an association between anticipated substance-use stigma and suboptimal ART adherence. The copy does not establish the separate claim about negative perceptions of addiction treatment. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Substance use stigma is linked with increased drug use and other HIV risk behaviors.

    “Substance use stigma is also linked with increased drug use and other HIV risk behaviors.5”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. Goffman E. Stigma: Notes on a Spoiled Identity. New York: Prentice Hall, 1963.
  2. Wilson I, Fowler J, Cosenza C, et al. Lessons from cog- nitive testing of self-report adherence items. In: 7th Inter- national Conference on HIV Treatment and Prevention Adherence. Miami Beach, FL, 2012.
  3. Kalichman SC, Kalichman MO, Cherry C, et al. Intentional medication non-adherence due to interactive toxicity be- liefs among HIV positive active drug users. J Acquir Im- mune Defic Syndr 2015;70:503.

Cited by

Sorted by citations

Authors
Stringer, K. L., Marotta, P., Baker, E., Turan, B., Kempf, M.-C., Drentea, P., Stepanikova, I., & Turan, J. M.
Affiliations
  • Columbia University (US)
  • University of Alabama at Birmingham (US)
  • Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Sociology, and University of Alabama at Birmingham, Birmingham, Alabama.
Corresponding author
Stringer, Kristi Lynn
Venue
AIDS Patient Care and STDs
Published
2019-06
Volume
33
Issue
6
Pages
282-293
ISSN
  • 1087-2914 (ISSN-L)
  • 1557-7449
OpenAlex
W2948391706
Cited by
54
References
69
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 15 · 2021: 10 · 2020: 8
FWCI
6.32
Type
journal article
Language
en
Open access
Locations
  • AIDS Patient Care and STDs (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Alabama at Birmingham (P30-AI-027767)
  • University of Alabama (T32HS013852, P30 AI027767)
  • National Institutes of Health (P30-AI- 027767, AI027767)
  • Agency for Healthcare Research and Quality (T32HS013852)
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute
  • National Institute on Drug Abuse (R01DA041063, F31DA044794, F31DA037106, R25DA037190, T32DA037801)
  • National Cancer Institute (T32HS013852)
  • National Institute of General Medical Sciences
  • National Institute of Allergy and Infectious Diseases (P30AI027767, AI027767)
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
substance use stigma, antiretroviral therapy adherence, people living with HIV, drug use, cocaine, cannabis, alcohol consumption, HIV stigma, social support, anticipated stigma, HIV prevention interventions
MeSH terms
Adult, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, HIV Infections, Drug Monitoring, Substance-Related Disorders, Antiretroviral Therapy, Highly Active, Anti-Retroviral Agents, Medication Adherence, Social Stigma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review